Citation:Taketani K, Tokunaga E, Yamashita N, Tanaka K, Akiyoshi S, Okada S, et al 2014

From Cancer Guidelines Wiki

Citation


Taketani K, Tokunaga E, Yamashita N, Tanaka K, Akiyoshi S, Okada S, et al. Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients. Surg Today 2014 Oct;44(10):1841-6 Available from: http://www.ncbi.nlm.nih.gov/pubmed/24142101.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Interruption of hormone therapyDr Jessica Harriscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:In breast cancer patients who want to become pregnant, does interrupting adjuvant hormone therapy to conceive increase the risk of cancer recurrence?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In breast cancer patients who want to become pregnant, does interrupting adjuvant hormone therapy to conceive increase the risk of cancer recurrence?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Interrupting hormone therapy to conceive